LARIMAR THERAPEUTICS INC (LRMR:NASDAQ)
$3.47 -0.13 (-3.6111%)
Analysed LARIMAR THERAPEUTICS INC (LRMR:NASDAQ) News Sources
Larimar Therapeutics (LRMR) Is Up 78.8% After Breakthrough Nod And $100M Raise Has The Bull Case Changed?
28-02-2026
yahoo.com
Larimar Therapeutics price target raised to $12 from $11 at Wedbush
04-03-2026
yahoo.com
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
04-03-2026
yahoo.com
LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?
06-03-2026
yahoo.com
Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
19-03-2026
yahoo.com
Larimar: Q4 Earnings Snapshot
19-03-2026
yahoo.com
Wedbush Raises its Price Target on Larimar Therapeutics (LRMR) to $13
27-03-2026
yahoo.com
Larimar Therapeutics Publishes Cross-Species Findings Supporting Skin as a Surrogate for the Measurement of Frataxin in Tissues Clinically Relevant to Friedreich’s Ataxia
30-04-2026
yahoo.com
Larimar Therapeutics Reports First Quarter 2026 Financial and Business Update
14-05-2026
yahoo.com
Exploring US High Growth Tech Stocks This May 2026
15-05-2026
yahoo.com
What is the current price of LARIMAR THERAPEUTICS INC (LRMR:NASDAQ)?
The current price of LARIMAR THERAPEUTICS INC (LRMR:NASDAQ) is $3.47.
LARIMAR THERAPEUTICS INC (LRMR:NASDAQ) absolute price change since previous trading day?
The absolute price change of LARIMAR THERAPEUTICS INC (LRMR:NASDAQ) since the previous trading day is $-0.13.
LARIMAR THERAPEUTICS INC (LRMR:NASDAQ) percentage price change since previous trading day?
The percentage price change of LARIMAR THERAPEUTICS INC (LRMR:NASDAQ) since the previous trading day is -3.6111%.
What is the most recent average sentiment score for LARIMAR THERAPEUTICS INC (LRMR:NASDAQ)?
The most recent average sentiment score for LARIMAR THERAPEUTICS INC (LRMR:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for LARIMAR THERAPEUTICS INC (LRMR:NASDAQ)?
The most recent sentiment for LARIMAR THERAPEUTICS INC (LRMR:NASDAQ) is .
SEC-8K** Filing Available For LARIMAR THERAPEUTICS INC (LRMR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.